Braveheart Investment Group PLC
LSE:BRH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (0), the stock would be worth GBX-0.09 (104% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.3 | GBX2.2 |
0%
|
| Industry Average | 0 | GBX-0.09 |
-104%
|
| Country Average | 0 | GBX-0.13 |
-106%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Braveheart Investment Group PLC
LSE:BRH
|
1.7m GBP | -0.3 | -0.3 | |
| US |
|
BlackRock Inc
NYSE:BLK
|
163.4B USD | 17.3 | 26.1 | |
| US |
|
Blackstone Inc
NYSE:BX
|
145.3B USD | 21.2 | 49.3 | |
| CA |
|
Brookfield Corp
NYSE:BN
|
101.8B USD | 11.2 | 89.7 | |
| US |
|
Bank of New York Mellon Corp
NYSE:BK
|
93.2B USD | 0 | 17.5 | |
| US |
|
KKR & Co Inc
NYSE:KKR
|
90.6B USD | 282.7 | 40.6 | |
| ZA |
N
|
Ninety One Ltd
JSE:NY1
|
82.3B ZAR | -38.5 | 24.2 | |
| CA |
B
|
BROOKFIELD ASSET MANAGEMENT LTD
TSX:BAM
|
107.2B CAD | 28.1 | 31.1 | |
| US |
|
BROOKFIELD ASSET MANAGEMENT LTD
F:RW5
|
67.3B EUR | 28.2 | 31.2 | |
| CA |
|
Brookfield Asset Management Inc
NYSE:BAM
|
78.3B USD | 28.4 | 31.5 | |
| US |
|
Ameriprise Financial Inc
NYSE:AMP
|
41.9B USD | 12.3 | 11.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 743.2 |
Other Multiples
Braveheart Investment Group PLC
Glance View
Braveheart Investment Group Plc engages in the provision of debt or equity and advisory services. The company is headquartered in Barnsley, South Yorkshire. The company went IPO on 2007-03-30. The firm holds investments in over five companies, including Phasefocus Holdings Limited, Paraytec Limited, Sentinel Medical Limited, Kirkstall Limited and Gyrometric Systems Limited. Its subsidiaries include Caledonia Portfolio Realisations Limited, Braveheart Academic Seed Funding GP Limited, Ridings Holdings Limited and The Ridings Early Growth Investment Company Limited. Its subsidiary, Kirkstall Limited, operates in the organ-on-a-chip market, where it has developed Quasi Vivo, a system of chambers for cell and tissue culture in laboratories. Its subsidiary, Paraytec Limited, develops high performance specialist detectors for the analytical and life sciences instrumentation market.
